Is This “Bathroom Pill” STEALING Your Memory?
With Thanksgiving here, holiday season is in full swing…
That means weeks of dinners with friends, visits to family members, and long shopping trips looking for the perfect gifts.
And for many seniors, it also means scouting for the nearest bathroom everywhere you go, worrying about embarrassing “leaks.”
But if you’re taking prescription drugs for an overactive bladder – or even incontinence—there’s something you need to know before you swallow that next pill.
Because some of the most popular meds around don’t just quiet your bladder…
They may be silently destroying your brain… and sending your dementia risk through the roof.
For millions of older adults, these incontinence medications have a dangerous—and well-documented—downside.
A downside that makes your brain foggier… your recall slower…
And your risk of dementia significantly higher the longer you take them.
The drugs I’m talking about are anticholinergics—medications that work by blocking a chemical messenger called acetylcholine.
In your bladder, acetylcholine helps the muscle contract. Blocking it can calm those sudden urges and leaks.
But acetylcholine doesn’t just live in your bladder.
It’s also one of your brain’s main memory and attention chemicals. When you block it, thinking gets slower, recall gets fuzzier, and over time your brain becomes a target for dementia.
That’s not a theory. It’s EXACTLY what long-term studies are finding.
A landmark 10-year study of more than 3,400 adults over 65 found that people with the highest cumulative exposure to strong anticholinergic drugs—including bladder medicines—had a significantly GREATER risk of developing dementia than those who took little or none.
When researchers zoomed in on just bladder drugs in another study, they found that long-term use of certain bladder anticholinergics—especially oxybutynin, solifenacin, and tolterodine—was linked to about a 20%–30% higher risk of dementia.
Put simply: for many seniors, the “bathroom pill” that promises freedom from leaks may be quietly making their brains more vulnerable.
Fortunately, you’re not stuck.
If you’re taking an anticholinergic incontinence drug, such as darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, or trospium, ask your doctor if there is a safer, non-drug approach you can try instead.
Because the truth is, these risky meds aren’t your only option.
One natural option with promising research is pumpkin seed extract—one of the few supplements shown in human studies to help reduce urgency, nighttime trips, and accidental leaks.
Unlike anticholinergics, it doesn’t come with a hidden price tag on your memory.
Your bladder deserves support and your brain deserves protection.
You should never have to sacrifice one for the other.
To protecting both,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
Sources:
- Gray, S. L., Anderson, M. L., Dublin, S., et al. (2015). Cumulative use of strong anticholinergics and incident dementia. JAMA Internal Medicine, 175(3), 401–407.
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2091745 - Iyen, B., Coupland, C., Bell, B. G., et al. (2024). Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years: Nested case-control study. BMJ Medicine, 3(1), e000799.
https://bmjmedicine.bmj.com/content/3/1/e000799 - Iyen, B., Coupland, C., Bell, B. G., et al. (2024). Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years: Nested case-control study. BMJ Medicine, 3(1), e000799.
https://bmjmedicine.bmj.com/content/3/1/e000799 - Malcher, M. F., et al. (2022). Dementia associated with anticholinergic drugs used for overactive bladder. Journal of Urology, 207(4), 779–787.
- https://pubmed.ncbi.nlm.nih.gov/35686842/
- Griebling, T. L., Campbell, N. L., Mangel, J., et al. (2020). Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR). BMC Geriatrics, 20, 109.
https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-020-1474-7 - Shim, B. S., et al. (2014). A randomized, double-blind, placebo-controlled trial of a product containing pumpkin seed extract and soy germ extract for overactive bladder. Journal of Functional Foods, 8, 111–118.
https://www.sciencedirect.com/science/article/abs/pii/S1756464614000826 - Nishimura, M., et al. (2014). Pumpkin seed oil extracted from Cucurbita maxima improves urinary disorder in human overactive bladder. Nutrition Research and Practice, 8(3), 253–257. https://pmc.ncbi.nlm.nih.gov/articles/PMC4032845/
